[Effect of furosemide on ouabain toxicity in guinea pigs (author's transl)]. 1978

M Minami, and T Otani, and M Sakurai, and K Kanamori, and A Miyamoto, and T Kobayashi, and H Yasuda, and H Togashi, and H Saito

An attempt was made to study the effect of furosemide on the toxic and lethal dose (LD) of ouabain. Ouabain was infused continuously in guinea pigs anesthetized with urethane. The toxic dose of ouabain was determined by the minimal dose which produced ventricular arrhythmias. The LD of ouabain was 300.8 +/- 13.8 microgram/kg (mean +/- SE) in control guinea pigs. When furosemide was administered in a dose of 2 mg/kg i.v. prior to ouabain, this was significantly decreased to 225.2 +/- 14.1 microgram/kg (P less than 0.01). Furosemide-treated guinea pigs also showed a marked decrease in toxic dose of ouabain. In another series of experiment, the ouabain uptake by the heart and its subcellular fraction were determined by the infusion of 3H-ouabain at a constant rate under the same experimental conditions aforementioned. Approximately 30% decrease in the LD of 3H-ouabain was also observed in the furosemide pretreated guinea pigs. 3H-ouabain concentration in blood, cardiac muscles and microsomal fraction were lower than control group. These findings suggest that potentiation of ouabain toxicity produced by furosemide is not associated with increased cardiac ouabain uptake, but with increased sensitivity at the site of action.

UI MeSH Term Description Entries
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D010042 Ouabain A cardioactive glycoside consisting of rhamnose and ouabagenin, obtained from the seeds of Strophanthus gratus and other plants of the Apocynaceae; used like DIGITALIS. It is commonly used in cell biological studies as an inhibitor of the NA(+)-K(+)-EXCHANGING ATPASE. Acocantherin,G-Strophanthin,Acolongifloroside K,G Strophanthin
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005665 Furosemide A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY. Frusemide,Fursemide,Errolon,Frusemid,Furanthril,Furantral,Furosemide Monohydrochloride,Furosemide Monosodium Salt,Fusid,Lasix
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions

Related Publications

M Minami, and T Otani, and M Sakurai, and K Kanamori, and A Miyamoto, and T Kobayashi, and H Yasuda, and H Togashi, and H Saito
February 1971, Nagoya journal of medical science,
M Minami, and T Otani, and M Sakurai, and K Kanamori, and A Miyamoto, and T Kobayashi, and H Yasuda, and H Togashi, and H Saito
February 1982, The Journal of toxicological sciences,
M Minami, and T Otani, and M Sakurai, and K Kanamori, and A Miyamoto, and T Kobayashi, and H Yasuda, and H Togashi, and H Saito
April 1981, Fukuoka igaku zasshi = Hukuoka acta medica,
M Minami, and T Otani, and M Sakurai, and K Kanamori, and A Miyamoto, and T Kobayashi, and H Yasuda, and H Togashi, and H Saito
January 1980, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
M Minami, and T Otani, and M Sakurai, and K Kanamori, and A Miyamoto, and T Kobayashi, and H Yasuda, and H Togashi, and H Saito
July 1981, Mykosen,
M Minami, and T Otani, and M Sakurai, and K Kanamori, and A Miyamoto, and T Kobayashi, and H Yasuda, and H Togashi, and H Saito
October 1981, Bratislavske lekarske listy,
M Minami, and T Otani, and M Sakurai, and K Kanamori, and A Miyamoto, and T Kobayashi, and H Yasuda, and H Togashi, and H Saito
December 1974, Japanese journal of pharmacology,
M Minami, and T Otani, and M Sakurai, and K Kanamori, and A Miyamoto, and T Kobayashi, and H Yasuda, and H Togashi, and H Saito
October 1992, Hearing research,
M Minami, and T Otani, and M Sakurai, and K Kanamori, and A Miyamoto, and T Kobayashi, and H Yasuda, and H Togashi, and H Saito
March 1976, Wiener klinische Wochenschrift,
M Minami, and T Otani, and M Sakurai, and K Kanamori, and A Miyamoto, and T Kobayashi, and H Yasuda, and H Togashi, and H Saito
September 1977, Nihon Jibiinkoka Gakkai kaiho,
Copied contents to your clipboard!